Author:
Dhillon Nanak,Jeon Nayeon,Gurkan Umut,Sen Gupta Anirban,Bonomo Robert,Drummy Lawrence,Zhang Mei,Chance Mark
Abstract
The history of military medicine and research is rife with examples of novel treatments and new approaches to heal and cure soldiers and others impacted by war’s devastation. In the 21st century, new threats, like climate change, are combined with traditional threats, like geopolitical conflict, to create novel challenges for our strategic interests. Extreme and inaccessible environments provide heightened risks for warfighter exposure to dangerous bacteria, viruses, and fungi, as well as exposure to toxic substances and extremes of temperature, pressure, or both providing threats to performance and eroding resilience. Back home, caring for our veterans is also a healthcare priority, and the diseases of veterans increasingly overlap with the health needs of an aging society. These trends of climate change, politics, and demographics suggest performance evaluation and resilience planning and response are critical to assuring both warfighter performance and societal health. The Cleveland ecosystem, comprising several hospitals, a leading University, and one of the nation’s larger Veteran’s Health Administration systems, is ideal for incubating and understanding the response to these challenges. In this review, we explore the interconnections of collaborations between Defense agencies, particularly Air Force and Army and academic medical center-based investigators to drive responses to the national health security challenges facing the United States and the world.
Publisher
Case Western Reserve University
Subject
Infectious Diseases,Microbiology (medical),Molecular Biology,Immunology,Immunology and Allergy
Reference46 articles.
1. 1. Suran M. New Federal Agency for Biomedical and Health Research. JAMA. 2022;327(20):1949-. doi: 10.1001/jama.2022.8175.
2. 2. Yeh KB, Du E, Olinger G, Boston D. Biotechnology and Biodefense Enterprise: An Industry Perspective on Defence Acquisition. Global Security: Health, Science and Policy. 2022;7(1):37-43. doi: 10.1080/23779497.2022.2102527.
3.
3. DeChant AK, Fening S, Haag M, Harte W, Chance MR. Optimizing biomedical discoveries as an engine of culture change in an academic medical center. J Clin Transl Sci. 2022;6(1):e19. doi: 10.1017/cts.2021.888. PubMed PMID: 35291218; PMCID: PMC8889224.
4.
4. Reizes O, Low M, Josyula VP, Ellis J, Vince DG. New programs for translating research to patient care: Lessons learned at the NIH Center for Accelerated Innovations at Cleveland Clinic. J Clin Transl Sci. 2021;5(1):e176. doi: 10.1017/cts.2021.849. PubMed PMID: 34849252; PMCID: PMC8596069.
5. 5. Mackenbach JP. The rise and fall of diseases: reflections on the history of population health in Europe since ca. 1700. Eur J Epidemiol. 2021;36(12):1199-205. doi: 10.1007/s10654-021-00719-7. PubMed PMID: 33611677; PMCID: PMC7896827.